147 related articles for article (PubMed ID: 30233784)
1. Repression of IGF-I-induced osteoblast migration by (-)-epigallocatechin gallate through p44/p42 MAP kinase signaling.
Kawabata T; Tokuda H; Sakai G; Fujita K; Matsushima-Nishiwaki R; Otsuka T; Kozawa O
Biomed Rep; 2018 Oct; 9(4):318-326. PubMed ID: 30233784
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol suppresses insulin-like growth factor I-induced osteoblast migration: attenuation of the p44/p42 MAP kinase pathway.
Hioki T; Kawabata T; Sakai G; Fujita K; Kuroyanagi G; Matsushima-Nishiwaki R; Kim W; Otsuka T; Iida H; Tokuda H; Kozawa O
Biosci Biotechnol Biochem; 2020 Dec; 84(12):2428-2439. PubMed ID: 32862787
[TBL] [Abstract][Full Text] [Related]
3. Involvement of p44/p42 MAP kinase in insulin-like growth factor-I-induced alkaline phosphatase activity in osteoblast-like-MC3T3-E1 cells.
Hanai Y; Tokuda H; Ishisaki A; Matsushima-Nishiwaki R; Nakamura N; Yoshida M; Takai S; Ohta T; Kozawa O
Mol Cell Endocrinol; 2006 Jun; 251(1-2):42-8. PubMed ID: 16616413
[TBL] [Abstract][Full Text] [Related]
4. HSP70 Inhibitor Suppresses IGF-I-Stimulated Migration of Osteoblasts through p44/p42 MAP Kinase.
Kawabata T; Tokuda H; Sakai G; Fujita K; Matsushima-Nishiwaki R; Kuroyanagi G; Otsuka T; Kozawa O
Biomedicines; 2018 Nov; 6(4):. PubMed ID: 30469446
[TBL] [Abstract][Full Text] [Related]
5. (-)-Epigallocatechin gallate suppresses endothelin-1-induced interleukin-6 synthesis in osteoblasts: inhibition of p44/p42 MAP kinase activation.
Tokuda H; Takai S; Hanai Y; Matsushima-Nishiwaki R; Hosoi T; Harada A; Ohta T; Kozawa O
FEBS Lett; 2007 Apr; 581(7):1311-6. PubMed ID: 17350626
[TBL] [Abstract][Full Text] [Related]
6. (-)-Epigallocatechin gallate but not chlorogenic acid suppresses EGF-stimulated migration of osteoblasts via attenuation of p38 MAPK activity.
Kawabata T; Otsuka T; Fujita K; Sakai G; Matsushima-Nishiwaki R; Kozawa O; Tokuda H
Int J Mol Med; 2018 Dec; 42(6):3149-3156. PubMed ID: 30272256
[TBL] [Abstract][Full Text] [Related]
7. (-)-Epigallocatechin gallate reduces platelet-derived growth factor-BB-stimulated interleukin-6 synthesis in osteoblasts: suppression of SAPK/JNK.
Takai S; Matsushima-Nishiwaki R; Adachi S; Natsume H; Minamitani C; Mizutani J; Otsuka T; Tokuda H; Kozawa O
Mediators Inflamm; 2008; 2008():291808. PubMed ID: 19148296
[TBL] [Abstract][Full Text] [Related]
8. Attenuation by HSP90 inhibitors of EGF-elicited migration of osteoblasts: involvement of p44/p42 MAP kinase.
Kuroyanagi G; Kawabata T; Tokuda H; Fujita K; Matsushima-Nishiwaki R; Sakai G; Tachi J; Hioki T; Kim W; Iida H; Otsuka T; Kozawa O
Connect Tissue Res; 2022 Jul; 63(4):359-369. PubMed ID: 34100663
[TBL] [Abstract][Full Text] [Related]
9. (-)-epigallocatechin gallate inhibits prostaglandin D2-stimulated HSP27 induction via suppression of the p44/p42 MAP kinase pathway in osteoblasts.
Yamauchi J; Takai S; Matsushima-Nishiwaki R; Hanai Y; Doi T; Kato H; Ogura S; Kato K; Tokuda H; Kozawa O
Prostaglandins Leukot Essent Fatty Acids; 2007; 77(3-4):173-9. PubMed ID: 17949962
[TBL] [Abstract][Full Text] [Related]
10. HSP70 Inhibitors Reduce The Osteoblast Migration By Epidermal Growth Factor.
Kawabata T; Otsuka T; Fujita K; Sakai G; Kim W; Matsushima-Nishiwaki R; Kuroyanagi G; Kozawa O; Tokuda H
Curr Mol Med; 2018; 18(7):486-495. PubMed ID: 30543167
[TBL] [Abstract][Full Text] [Related]
11. (-)-Epigallocatechin gallate amplifies interleukin-1-stimulated interleukin-6 synthesis in osteoblast-like MC3T3-E1 cells.
Kuroyanagi G; Otsuka T; Kondo A; Matsushima-Nishiwaki R; Mizutani J; Kozawa O; Tokuda H
Biochimie; 2013 Oct; 95(10):1933-8. PubMed ID: 23851196
[TBL] [Abstract][Full Text] [Related]
12. p70 S6 kinase limits tumor necrosis factor-alpha-induced interleukin-6 synthesis in osteoblast-like cells.
Minamitani C; Tokuda H; Adachi S; Matsushima-Nishiwaki R; Yamauchi J; Kato K; Natsume H; Mizutani J; Kozawa O; Otsuka T
Mol Cell Endocrinol; 2010 Feb; 315(1-2):195-200. PubMed ID: 19879324
[TBL] [Abstract][Full Text] [Related]
13. HSP90 inhibitors diminish PDGF-BB-induced migration of osteoblasts via suppression of p44/p42 MAP kinase.
Kawabata T; Tokuda H; Fujita K; Matsushima-Nishiwaki R; Sakai G; Tachi J; Hioki T; Kim W; Iida H; Otsuka T; Kozawa O
Biomed Res; 2019; 40(4):169-178. PubMed ID: 31413238
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol Inhibits the Epidermal Growth Factor-Induced Migration of Osteoblasts: the Suppression of SAPK/JNK and Akt.
Kawabata T; Tokuda H; Fujita K; Kainuma S; Sakai G; Matsushima-Nishiwaki R; Kozawa O; Otsuka T
Cell Physiol Biochem; 2017; 43(3):1025-1036. PubMed ID: 28968596
[TBL] [Abstract][Full Text] [Related]
15. Oncostatin M attenuates tumor necrosis factor-α-induced synthesis of macrophage-colony stimulating factor via suppression of Akt in osteoblasts.
Hioki T; Kuroyanagi G; Matsushima-Nishiwaki R; Kozawa O; Tokuda H
Connect Tissue Res; 2023 Mar; 64(2):139-147. PubMed ID: 35986560
[TBL] [Abstract][Full Text] [Related]
16. p38 MAP kinase regulates BMP-4-stimulated VEGF synthesis via p70 S6 kinase in osteoblasts.
Tokuda H; Hatakeyama D; Shibata T; Akamatsu S; Oiso Y; Kozawa O
Am J Physiol Endocrinol Metab; 2003 Jun; 284(6):E1202-9. PubMed ID: 12637256
[TBL] [Abstract][Full Text] [Related]
17. Basic fibroblast growth factor stimulates vascular endothelial growth factor release in osteoblasts: divergent regulation by p42/p44 mitogen-activated protein kinase and p38 mitogen-activated protein kinase.
Tokuda H; Kozawa O; Uematsu T
J Bone Miner Res; 2000 Dec; 15(12):2371-9. PubMed ID: 11127202
[TBL] [Abstract][Full Text] [Related]
18. Negative regulation by p70 S6 kinase of FGF-2-stimulated VEGF release through stress-activated protein kinase/c-Jun N-terminal kinase in osteoblasts.
Takai S; Tokuda H; Hanai Y; Harada A; Yasuda E; Matsushima-Nishiwaki R; Kato H; Ogura S; Ohta T; Kozawa O
J Bone Miner Res; 2007 Mar; 22(3):337-46. PubMed ID: 17181399
[TBL] [Abstract][Full Text] [Related]
19. (--)-epigallocatechin gallate enhances prostaglandin F2alpha-induced VEGF synthesis via upregulating SAPK/JNK activation in osteoblasts.
Tokuda H; Takai S; Matsushima-Nishiwaki R; Akamatsu S; Hanai Y; Hosoi T; Harada A; Ohta T; Kozawa O
J Cell Biochem; 2007 Apr; 100(5):1146-53. PubMed ID: 17031857
[TBL] [Abstract][Full Text] [Related]
20. (-)-Epigallocatechin gallate inhibits thyroid hormone-stimulated osteocalcin synthesis in osteoblasts.
Kato K; Otsuka T; Adachi S; Matsushima-Nishiwaki R; Natsume H; Kozawa O; Tokuda H
Mol Med Rep; 2011; 4(2):297-300. PubMed ID: 21468567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
